重症监护病房血小板输注实践:Nine-I国际血小板输注调查
该研究为在线匿名调查,含43个条目,以法语和英语两种语言制作,由Nine-I研究网络的研究者分发至欧洲和美国的ICU医生,评估有无出血ICU患者的血小板输注实践、当地指南存在情况及影响输注决策的因素,仅分析完整问卷。共收到997份由ICU医生完成的问卷,国家间及国家内血小板输注实践存在很大异质性;在无出血的血小板减少内科ICU患者中,多数会在血小板计数阈值为10 × 109 cells/L时输注预防性血小板;30%在骨髓衰竭患者中会改变策略,其中60%(95%置信限0.54, 0.66)更宽松、31%(0.26, 0.36)更严格或寻求帮助;外科患者、操作前及出血患者偏好更高阈值;仅173人(17%;0.15, 0.19)表示每次开具血小板输注时对临床指征有信心,仅123人(12%;0.10, 0.15)表示总是阅读现有指南;同事态度和科室文化是输血实践的重要影响因素。
要点
- 在无出血的血小板减少内科ICU患者中,多数医生会在血小板计数阈值10 × 109 cells/L时输注预防性血小板。
- 30%的医生在骨髓衰竭患者中会改变策略:60%(95%置信限0.54, 0.66)更宽松、31%(0.26, 0.36)更严格或寻求帮助。
- 外科患者、操作前及出血患者偏好更高的血小板输注阈值。
- 仅173人(17%;0.15, 0.19)每次输注时对临床指征有信心,仅123人(12%;0.10, 0.15)总是阅读指南。
- 同事态度和科室文化是血小板输注实践的重要影响因素。
适用人群与场景
- 欧洲和美国的ICU医生,评估有无出血的ICU患者。
- 无出血的血小板减少内科ICU患者、骨髓衰竭患者、外科患者、操作前患者及出血患者。
研究设计与关键结果
- 研究类型为在线匿名调查,含43个条目,以法语和英语两种语言制作,由Nine-I研究网络的研究者分发至欧洲和美国的ICU医生,仅分析完整问卷,共收到997份由ICU医生完成的问卷。
- 国家间及国家内血小板输注实践存在很大异质性。
- 在无出血的血小板减少内科ICU患者中,多数会在血小板计数阈值10 × 109 cells/L时输注预防性血小板。
- 30%的医生在骨髓衰竭患者中会改变策略:60%(95%置信限0.54, 0.66)更宽松、31%(0.26, 0.36)更严格或寻求帮助。
- 外科患者、操作前及出血患者偏好更高阈值。
- 仅173人(17%;0.15, 0.19)每次开具血小板输注时对临床指征有信心,仅123人(12%;0.10, 0.15)总是阅读现有指南。
- 同事态度和科室文化是输血实践的重要影响因素。
证据类型、等级与局限
- 证据类型:在线匿名调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Platelet transfusions are frequent in the Intensive Care Unit (ICU), either as prophylaxis against bleeding complications or as treatment for bleeding. The European Society of Intensive Care Medicine guidelines for ICU patients generally recommend not using prophylactic platelet transfusions unless the platelet count falls below 10 × 109 cells/L in non-bleeding patients and make no recommendation for platelet transfusion threshold in non-massively bleeding patients with thrombocytopenia. Therefore, the decision to transfuse platelets is often left to clinical assessment by the treating physician. This study aims to describe current platelet transfusion preferences among ICU physicians.
METHODS: An online, anonymous survey consisting of 43 items was produced in two languages (French and English) and distributed by investigators in the Nine-I research network to ICU physicians in Europe and the United States of America. The survey evaluated platelet transfusion practices in ICU patients with and without bleeding, the presence of local guidelines, and factors influencing the decisions to transfuse platelets. Only completed surveys were analysed.
RESULTS: We received 997 surveys completed by ICU physicians. Overall, there was large heterogeneity in platelet transfusion practices between and within countries. In non-bleeding, thrombocytopenic medical ICU patients, most would transfuse prophylactic platelets at a platelet count threshold of 10 × 109 cells/L. Thirty percent would change their strategy in patients with bone marrow failure and either be more liberal (60%; 95% Confidence Limits 0.54, 0.66), more restrictive (31%; 0.26,0.36) or seek assistance. Higher thresholds were preferred in surgical patients, prior to procedures and in patients with bleeding. Only 173 (17%; 0.15,0.19) responded that they were confident about the clinical indications every time they prescribed a platelet transfusion. As for existing guidelines, only 123 (12%; 0.10,0.15) responded that they always read them. Colleagues' attitudes and departmental culture were important influencers on transfusion practice.
CONCLUSION: Platelet transfusion practice in the ICU is heterogeneous, both between and within countries; guidelines are often not used, and there is often uncertainty about the clinical indication.
参考来源
- Russell L, Azoulay E, Anthon CT, et al. Platelet transfusion practice in the intensive care unit: the Nine-I international platelet transfusion survey. Ann Intensive Care. 2025. PMID: 40627074. doi:10.1186/s13613-025-01494-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。